Immunome’s CEO, Clay B. Siegall, purchased 46,511 shares of IMNM on Thursday for $999,986, equating to $21.50 per share. This purchase follows two previous investments totaling $2.16 million at an average price of $7.53 over the past year. As of Friday, Immunome shares were up approximately 7.9%.
Additionally, on Tuesday, SentinelOne’s Director Mark S. Peek bought 40,000 shares at $14.89 each, amounting to a total of $595,600. On the same Friday, SentinelOne shares were trading up about 0.3%, with a current price of $14.61, making it 1.9% below Peek’s purchase price.
